217.5403 Eligibility requirements for treatment with investigational drug, biological product, or device. A patient shall be eligible for treatment with an investigational drug, biological product, or device if the patient has: (1) A terminal illness tha t is attested to by the patient's treating health care provider; (2) Considered all other treatment options currently approved by the United States Food and Drug Administration; (3) Received a recommendation from the patient's treating health care provider for an investigational drug, biological product, or device; (4) Given written informed consent for the use of the investigational drug, biological product, or device; and (5) Documentation from the treating health care provider that the patient meets the requirements of this section. Effective: June 29, 2017 History: Created 2017 Ky. Acts ch. 65, sec. 3, effective June 29, 2017. Formerly codified as KRS 217.5405.
Kentucky Legal Code